STEVEN PRESTRELSKI - Chief Scientific Officer at Xeris Biopharma Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
XERS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by STEVEN PRESTRELSKI since 11 Feb 2025

Holdings reported by STEVEN PRESTRELSKI for Xeris Biopharma Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 719,780 $1,345,989 $1.87 31 Jan 2023 Direct
Stock Option (Right to Buy) 0 $2.37 22 Feb 2022 Direct Common Stock

Transactions reported by STEVEN PRESTRELSKI for Xeris Biopharma Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.